Selected-GenAtlas references | SOURCE | GeneCards | NCBI Gene | Swiss-Prot | Ensembl |
HGNC | UniGene | Nucleotide | OMIM | UCSC |
Home Page |
FLASH GENE |
Symbol | MAP3K8 | contributors: mct - updated : 16-01-2019 |
HGNC name | mitogen-activated protein kinase kinase kinase 8 |
HGNC id | 6860 |
|
Location | 10p11.23 Physical location : 30.722.865 - 30.750.761 |
Synonym name | |
| |
| |
| |
| |
Synonym symbol(s) | COT, TPL2, EST, ESTF, MEKK8, Tpl-2, c-COT, FLJ10486 |
EC.number | 2.7.11.25 |
DNA |
TYPE | functioning gene |
STRUCTURE | 27.90 kb 9 Exon(s) |
10 Kb 5' upstream gene genomic sequence study |
---|
regulatory sequence | Promoter (TATA box) |
MAPPING | cloned | Y | linked | status | confirmed |
Map | pter - D10S1684 - MAP3K8 - D10S1695 - D10S193 - qter |
RNA |
TRANSCRIPTS | type | messenger |
---|
EXPRESSION |
Type | widely |
expressed in | (based on citations) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
organ(s) |
|
cell lineage
cell lines
| fluid/secretion
| blood | |
at STAGE |
physiological period | neonatal, pregnancy |
cell cycle | cell cycle, S, checkpoint, G2M |
Text | umbilical cord |
PROTEIN |
PHYSICAL PROPERTIES
STRUCTURE
| |
motifs/domains
|
conjugated | PhosphoP |
HOMOLOGY |
interspecies | homolog to rattus Map3k8 (94.00 pc) |
homolog to murine Map3k8 (93.36 pc) |
Homologene |
FAMILY | |
|
CATEGORY | enzyme , protooncogene |
SUBCELLULAR LOCALIZATION | intracellular |
intracellular,cytoplasm,cytosolic |
basic FUNCTION | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
CELLULAR PROCESS | cell cycle, checkpoint |
PHYSIOLOGICAL PROCESS |
PATHWAY |
metabolism |
signaling | signal transduction |
a component |
INTERACTION |
DNA |
RNA |
small molecule | metal binding, cofactor, nucleotide, |
|
protein | |
| |
|
cell & other |
REGULATION |
activated by | IL1 stimulated activation of the MAP3K8 catalytic subunit | |
through the phosphorylation of Thr290 and Ser62 |
induced by | IL12 in a Stat4-dependent manner |
Other | up-regulated by BCL11B |
autophosphorylated | |
activated specifically during the S and G2/M phases of the cell cycle |
ASSOCIATED DISORDERS |
corresponding disease(s) |
Other morbid association(s) |
|
Susceptibility |
Variant & Polymorphism
| |
Candidate gene | |||||||||||||||
Marker
Therapy target
|
|
|
|
ANIMAL & CELL MODELS |